OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Calming the Storm: Natural Immunosuppressants as Adjuvants to Target the Cytokine Storm in COVID-19
Angela E. Peter, B. V. Sandeep, B. Ganga Rao, et al.
Frontiers in Pharmacology (2021) Vol. 11
Open Access | Times Cited: 83

Showing 1-25 of 83 citing articles:

Flavonols and Flavones as Potential anti-Inflammatory, Antioxidant, and Antibacterial Compounds
Maria do Socorro S. Chagas, Maria Dutra Behrens, Carla Junqueira Moragas Tellis, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-21
Open Access | Times Cited: 176

The multifaceted nature of IL-10: regulation, role in immunological homeostasis and its relevance to cancer, COVID-19 and post-COVID conditions
Valentina Carlini, Douglas M. Noonan, Eslam Abdalalem, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 138

Could SARS-CoV-2 Spike Protein Be Responsible for Long-COVID Syndrome?
Theoharis C. Theoharides
Molecular Neurobiology (2022) Vol. 59, Iss. 3, pp. 1850-1861
Open Access | Times Cited: 125

COVID-19 Causes Ferroptosis and Oxidative Stress in Human Endothelial Cells
Stanislovas S. Jankauskas, Urna Kansakar, Celestino Sardu, et al.
Antioxidants (2023) Vol. 12, Iss. 2, pp. 326-326
Open Access | Times Cited: 42

Garlic (Allium sativum L.) Bioactives and Its Role in Alleviating Oral Pathologies
Minnu Sasi, Sandeep Kumar, Manoj Kumar, et al.
Antioxidants (2021) Vol. 10, Iss. 11, pp. 1847-1847
Open Access | Times Cited: 71

Interleukin-6 Perpetrator of the COVID-19 Cytokine Storm
Jyoti Shekhawat, Kavya Gauba, Shruti Gupta, et al.
Indian Journal of Clinical Biochemistry (2021) Vol. 36, Iss. 4, pp. 440-450
Open Access | Times Cited: 70

Low-Molecular-Weight Synthetic Antioxidants: Classification, Pharmacological Profile, Effectiveness and Trends
Mihaela Stoia, Simona Oancea
Antioxidants (2022) Vol. 11, Iss. 4, pp. 638-638
Open Access | Times Cited: 44

Interleukin-1 blocking agents for treating COVID-19
Mauricia Davidson, Sonia Menon, Anna Chaimani, et al.
Cochrane library (2022) Vol. 2022, Iss. 1
Open Access | Times Cited: 37

Mast cell activation is associated with post‐acute COVID‐19 syndrome
Joshua B. Wechsler, Melina Butuci, Alan Wong, et al.
Allergy (2021) Vol. 77, Iss. 4, pp. 1288-1291
Open Access | Times Cited: 48

Luteolin inhibits spike protein of severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) binding to angiotensin‐converting enzyme 2
Junjie Zhu, Huimin Yan, Mengyao Shi, et al.
Phytotherapy Research (2023) Vol. 37, Iss. 8, pp. 3508-3521
Closed Access | Times Cited: 15

Vaccination and multiple sclerosis in the era of the COVID-19 pandemic
Tobias Monschein, Hans‐Peter Hartung, Tobias Zrzavy, et al.
Journal of Neurology Neurosurgery & Psychiatry (2021) Vol. 92, Iss. 10, pp. 1033-1043
Open Access | Times Cited: 36

Mucormycosis Amid COVID-19 Crisis: Pathogenesis, Diagnosis, and Novel Treatment Strategies to Combat the Spread
S Dogra, Akanksha Arora, Aashni Aggarwal, et al.
Frontiers in Microbiology (2022) Vol. 12
Open Access | Times Cited: 25

A New Butyrate Releaser Exerts a Protective Action against SARS-CoV-2 Infection in Human Intestine
Lorella Paparo, Maria Maglio, Maddalena Cortese, et al.
Molecules (2022) Vol. 27, Iss. 3, pp. 862-862
Open Access | Times Cited: 22

Pyronaridine Protects against SARS-CoV-2 Infection in Mouse
Ana C. Puhl, Giovanni Freitas Gomes, Samara Damasceno, et al.
ACS Infectious Diseases (2022) Vol. 8, Iss. 6, pp. 1147-1160
Open Access | Times Cited: 22

Microglial Inflammatory Responses to SARS‐CoV‐2 Infection: A Comprehensive Review
Rajen Dey, Biswadev Bishayi
Cellular and Molecular Neurobiology (2023) Vol. 44, Iss. 1
Closed Access | Times Cited: 13

Inhibitory effect of food-functioned phytochemicals on dysregulated inflammatory pathways triggered by SARS-CoV-2: a mechanistic review
Ibrahim Jantan, Nor Azrina Norahmad, Yuandani Yuandani, et al.
Critical Reviews in Food Science and Nutrition (2024), pp. 1-26
Closed Access | Times Cited: 3

Analysis of the key genes of Lactobacillus reuteri strains involved in the protection of alcohol-induced intestinal barrier damage
Jiayi Zhang, Chengcheng Zhang, Leilei Yu, et al.
Food & Function (2024) Vol. 15, Iss. 12, pp. 6629-6641
Closed Access | Times Cited: 3

APE1/Ref-1 – One Target with Multiple Indications: Emerging Aspects and New Directions
Mahmut Mijit, Rachel A. Caston, Silpa Gampala, et al.
Journal of Cellular Signaling (2021) Vol. 2, Iss. 3
Open Access | Times Cited: 28

Selenium, selenoprotein P, and oxidative stress levels in SARS-CoV-2 patients during illness and recovery
Andrejs Šķesters, Dmitrijs Kustovs, Anna Lece, et al.
Inflammopharmacology (2022) Vol. 30, Iss. 2, pp. 499-503
Open Access | Times Cited: 20

The Importance of Nutraceuticals in COVID-19: What’s the Role of Resveratrol?
Elisa Domi, Malvina Hoxha, Entela Kolovani, et al.
Molecules (2022) Vol. 27, Iss. 8, pp. 2376-2376
Open Access | Times Cited: 20

Natural products as a source of novel drugs for treating SARS-CoV2 infection
Ciro Isidoro, Ashley Chang, Lee‐Yan Sheen
Journal of Traditional and Complementary Medicine (2022) Vol. 12, Iss. 1, pp. 1-5
Open Access | Times Cited: 19

Comparative anticancer effects of Annona muricata Linn (Annonaceae) leaves and fruits on DMBA-induced breast cancer in female rats
Kevine Kamga Silihe, William Defo Mbou, Judith Christiane Ngo Pambe, et al.
BMC Complementary Medicine and Therapies (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 9

Colchicine Is Safe Though Ineffective in the Treatment of Severe COVID-19: a Randomized Clinical Trial (COLCHIVID)
Abdiel Absalón‐Aguilar, Marina Rull‐Gabayet, Alfredo Pérez‐Fragoso, et al.
Journal of General Internal Medicine (2021) Vol. 37, Iss. 1, pp. 4-14
Open Access | Times Cited: 25

Differential reinforcement of intestinal barrier function by various Lactobacillus reuteri strains in mice with DSS-induced acute colitis
Chunxiu Lin, Yuxing Zheng, Jingyu Lu, et al.
Life Sciences (2022) Vol. 314, pp. 121309-121309
Closed Access | Times Cited: 15

Page 1 - Next Page

Scroll to top